Open Access Open Access  Restricted Access Subscription or Fee Access

Physician survey examining the impact of an educational tool for responsible opioid prescribing

Aaron Young, PhD, Kelly C. Alfred, MS, Philip P. Davignon, MA, LaSharn M. Hughes, MBA, Lisa A. Robin, MLA, Humayun J. Chaudhry, DO

Abstract


Introduction: In response to the need for physician education on proper opioid prescribing, the Federation of State Medical Boards (FSMB) and the FSMB Foundation, the philanthropic arm of the FSMB, commissioned and distributed Responsible Opioid Use: A Physician’s Guide to more than 165,000 licensed physicians in the United States. The book, written by pain management specialist Scott Fishman, MD, seeks to further physicians’ continuing medical education by providing information on how to properly prescribe opioids to treat patients in pain. Although the book has been widely distributed, there have been no systematic studies of its impact. To address this knowledge gap, the authors surveyed licensed physicians in Georgia who received a copy of the book to determine whether it added to their knowledge about prescribing opioids, and if they planned to make changes in their practice based on reading the book.
Methods: Six weeks after licensed physicians in Georgia received the book, a survey was sent to 12,666 of them via e-mail.
Results: A total of 508 physicians completed the online survey. Of these, 82.1 percent rated the book either “very good” or “good” on providing pragmatic steps for improved care for patients in pain, and more than 80 percent agreed that the book is a useful educational tool. Almost one-third (32.2 percent) claimed that they intend to make changes to their practice after reading the book. The analysis also showed physicians in a solo practice were more likely to make changes (41.8 percent) than their counterparts in office-based group practice (33.3 percent) and hospital-based (25.0 percent) settings. Primary care providers (41.6 percent) were also much more likely to make changes than physicians working in other specialty areas of medicine (22.8 percent). Well over half (57.7 percent) of the respondents indicated the book was better than other publications they had read on opioid prescribing and pain management.
Conclusions: The results from this state-wide survey of licensed physicians demonstrate the value of educating physicians about how to appropriately prescribe, document, and treat patients who need opioid medications for pain management. The findings should be of value to organizations seeking to better educate physicians about appropriate opioid prescribing by providing insight into which physician population would be the most receptive to the type of information presented in Dr. Fishman’s book. When faced with limited resources, an organizational strategy that first targets solo and primary care practitioners may improve physician educational efforts about prescribing opioids better than a strategy targeting medical and surgical specialists or those physicians participating in group practice settings.


Keywords


pain management, opioids, prescribing, continuing medical education

Full Text:

PDF

References


IOM (Institute of Medicine): Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press, 2011.

Monitoring the Future: National results on adolescent drug use. Overview of key findings: 2010. Available at http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2010.pdf. Accessed October 26, 2011.

Manchikanti L, Fellow B, Ailinani H, et al.: Therapeutic use, abuse and nonmedical use of opioids: A ten year perspective. Pain Physician. 2010; 13(5): 401-435.

Okie, S: A flood of opioids, a rising tide of deaths. N Engl J Med. 2010; 363(21): 1981-1985.

Cratty C: Drug abuse costs rival those of chronic diseases, report says. Available at http://www.cnn.com/2011/HEALTH/05/26/drug.abuse.costs/index.html. Accessed May 27, 2011.

Drug Enforcement Administration: Office of diversion control. Practitioner’s manual. Available at http://www.deadiversion.usdoj.gov/pubs/manuals/pract/section5.htm. Accessed November 9, 2011.

Knight PJ: Prescribing opioids during the diversion crackdown. WMJ. 2010; 109(5): 291-292.

Goldenbaum D, Christopher M, Gallagher RM, et al.: Physicians charged with opioid analgesic-prescribing offenses. Pain Med. 2008; 9(6): 737-747.

Balance, Uniformity and Fairness: Effective Strategies for Law Enforcement for Investigating and Prosecuting the Diversion of Prescription Pain Medications While Protecting Appropriate Medical Practice. Available at http://www.fsmb.org/pdf/pub_bbpi_policy_brief.pdf. Accessed March 8, 2012.

Continuing Medical Education Overview by State. Available at http://www.fsmb.org/pdf/GRPOL_CME_Overview_by_State.pdf. Accessed November 2, 2011.

Prescription Monitoring Programs: Alliance of states with prescription monitoring programs. Available at http://www.deadiversion.usdoj.gov/mtgs/drug_chemical/2010/jgiglio.pdf. Accessed November 2, 2011.

Prescription Monitoring Programs (PMPs) Overview by state. Available at http://www.fsmb.org/pdf/GRPOL_pmp_overview_by_state.pdf. Accessed March 12, 2012.

Prescription Monitoring Programs. Available at http://www.pmpalliance.org/pdf/PPTs/LI2010/1-PMP-Overview-History.pdf. Accessed October 11, 2011.

Baehren DF, Marco CA, Droz DE, et al.: A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010; 56(1): 19-23.

Staying Clear of the Law and Addiction: Nevada’s pre-criminal intervention program. Available at http://www.pmpexcellence.org/sites/all/pdfs/2_nevada_pcip_nff_1_19_11.pdf;. Updated January 2011. Accessed October 26, 2011.

GAO Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. Available at http://www.gao.gov/new.items/d02634.pdf. Updated May 2002. Accessed October 26, 2011.

Federation of State Medical Boards: Model policy for the use of controlled substances for the treatment of pain. Available at http://www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf. Accessed July 22, 2011.

Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain. 2009; 10(2): 113-130.

Sinatra R: Opioid analgesics in primary care: Challenges and new advances in the management of noncancer pain. J Am Board Family Med. 2006; 19(2): 165-177.

US Food and Drug Administration: Questions and answers: FDA requires a risk evaluation and mitigation strategy (REMS) for long-acting and extended-release opioids. Available at http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm251752.htm. Accessed November 3, 2011.

Slevin, K, Ashburn M: Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies. J Opioid Manag. 2011; 7(2): 109-115.

Fishman S: Responsible Opioid Prescribing: A Physician’s Guide. Washington, DC: Waterford Life Sciences, 2007.

Federation of State Medical Boards: Summary of 2010 Board Actions. Available at http://www.fsmb.org/pdf/2010-summaryof-board-actions.pdf. Accessed January 24, 2012.

Guidelines for the Use of Controlled Substances for the Treatment of Pain: Ten Steps. Available at http://www.painpolicy.wisc.edu/domestic/states/GA/GAmbgl.pdf. Accessed July 21, 2011.

Manchikanti L, Ailinani H, Koyyalagunta D, et al.: A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011; 14(2): 91-121.

Manchikanti L, Vallejo R, Manchikanti KN, et al.: Effectiveness of long-term opioid therapy for chronic non-cancer pain. Pain Physician. 2011; 14(2): 133-156.

Shih T, Fan X: Comparing response rates from web and mail surveys: A meta-analysis. Field Methods. 2008; 20(3): 249-271.




DOI: https://doi.org/10.5055/jom.2012.0100

Refbacks

  • There are currently no refbacks.